200 related articles for article (PubMed ID: 35997843)
1. A new immunochemotherapy schedule for visceral leishmaniasis in a hamster model.
de Santana FR; da Silva DAM; Katz S; Orikaza CM; Oliveira KC; Barbiéri CL
Parasitol Res; 2022 Oct; 121(10):2849-2860. PubMed ID: 35997843
[TBL] [Abstract][Full Text] [Related]
2. Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging.
Reimão JQ; Oliveira JC; Trinconi CT; Cotrim PC; Coelho AC; Uliana SR
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003556. PubMed ID: 25679212
[TBL] [Abstract][Full Text] [Related]
3. Use of a recombinant cysteine proteinase from Leishmania (Leishmania) infantum chagasi for the Immunotherapy of canine visceral Leishmaniasis.
Ferreira JH; Silva Ldos S; Longo-Maugéri IM; Katz S; Barbiéri CL
PLoS Negl Trop Dis; 2014 Mar; 8(3):e2729. PubMed ID: 24625516
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of the use of miltefosine, miltefosine plus allopurinol, and allopurinol in dogs with visceral leishmaniasis.
Dias ÁFLR; Ayres EDCBS; de Oliveira Martins DT; Maruyama FH; de Oliveira RG; de Carvalho MR; Almeida ADBPF; Teixeira ALS; Mendonça AJ; Sousa VRF
Exp Parasitol; 2020 Oct; 217():107947. PubMed ID: 32628971
[TBL] [Abstract][Full Text] [Related]
5. LEISHMANICIDAL ACTIVITY in vivo OF A MILTEFOSINE DERIVATIVE IN Mesocricetus auratus.
da Silva JC; Nunes JB; Gontijo VS; Malaquias LCC; de Freitas RP; Alves RB; Colombo FA; Laurenti MD; Marques MJ
Acta Trop; 2020 Sep; 209():105539. PubMed ID: 32461110
[TBL] [Abstract][Full Text] [Related]
6. Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol.
Gonçalves G; Campos MP; Gonçalves AS; Medeiros LCS; Figueiredo FB
Parasit Vectors; 2021 Dec; 14(1):599. PubMed ID: 34886876
[TBL] [Abstract][Full Text] [Related]
7. Molecular detection of infection homogeneity and impact of miltefosine treatment in a Syrian golden hamster model of Leishmania donovani and L. infantum visceral leishmaniasis.
Eberhardt E; Mondelaers A; Hendrickx S; Van den Kerkhof M; Maes L; Caljon G
Parasitol Res; 2016 Oct; 115(10):4061-70. PubMed ID: 27412759
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and disposition of miltefosine in healthy mice and hamsters experimentally infected with Leishmania infantum.
Jiménez-Antón MD; García-Calvo E; Gutiérrez C; Escribano MD; Kayali N; Luque-García JL; Olías-Molero AI; Corral MJ; Costi MP; Torrado JJ; Alunda JM
Eur J Pharm Sci; 2018 Aug; 121():281-286. PubMed ID: 29883726
[TBL] [Abstract][Full Text] [Related]
9. Immunochemotherapy for visceral leishmaniasis: combinatorial action of Miltefosine plus LBSapMPL vaccine improves adaptative Th1 immune response with control of splenic parasitism in experimental hamster model.
Carvalho LM; Gusmão MR; Costa AFP; de Brito RCF; Aguiar-Soares RDO; Cardoso JMO; Reis AB; Carneiro CM; Roatt BM
Parasitology; 2022 Mar; 149(3):371-379. PubMed ID: 35264268
[TBL] [Abstract][Full Text] [Related]
10. Clinical and parasitological impact of short-term treatment using miltefosine and allopurinol monotherapy or combination therapy in canine visceral leishmaniasis.
Ayres EDCBS; Dias ÁFLR; Monteiro BRG; Pazzini SS; Barbosa MEC; Silva EBD; Macedo LFDC; Sousa VRF; Dutra V; Nakazato L; Almeida ADBPF
Rev Bras Parasitol Vet; 2022; 31(3):e007222. PubMed ID: 35920471
[TBL] [Abstract][Full Text] [Related]
11. A recombinant cysteine proteinase from Leishmania (Leishmania) chagasi as an antigen for delayed-type hypersensitivity assays and serodiagnosis of canine visceral leishmaniasis.
Pinheiro PH; Pinheiro AN; Ferreira JH; Costa FA; Katz S; Barbiéri CL
Vet Parasitol; 2009 May; 162(1-2):32-9. PubMed ID: 19269098
[TBL] [Abstract][Full Text] [Related]
12. Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis.
Manna L; Vitale F; Reale S; Picillo E; Neglia G; Vescio F; Gravino AE
Vet J; 2009 Dec; 182(3):441-5. PubMed ID: 18818112
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of miltefosine for the treatment of dogs naturally infected with L. infantum (=L. chagasi) in Brazil.
Andrade HM; Toledo VP; Pinheiro MB; Guimarães TM; Oliveira NC; Castro JA; Silva RN; Amorim AC; Brandão RM; Yoko M; Silva AS; Dumont K; Ribeiro ML; Bartchewsky W; Monte SJ
Vet Parasitol; 2011 Sep; 181(2-4):83-90. PubMed ID: 21641721
[TBL] [Abstract][Full Text] [Related]
14. Combination of liposomal CpG oligodeoxynucleotide 2006 and miltefosine induces strong cell-mediated immunity during experimental visceral leishmaniasis.
Shivahare R; Vishwakarma P; Parmar N; Yadav PK; Haq W; Srivastava M; Gupta S; Kar S
PLoS One; 2014; 9(4):e94596. PubMed ID: 24732039
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppression of Syrian golden hamsters accelerates relapse but not the emergence of resistance in Leishmania infantum following recurrent miltefosine pressure.
Hendrickx S; Bulté D; Van den Kerkhof M; Cos P; Delputte P; Maes L; Caljon G
Int J Parasitol Drugs Drug Resist; 2019 Apr; 9():1-7. PubMed ID: 30562667
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma (INF-gamma), IL4 expression levels and Leishmania DNA load as prognostic markers for monitoring response to treatment of leishmaniotic dogs with miltefosine and allopurinol.
Manna L; Reale S; Picillo E; Vitale F; Gravino AE
Cytokine; 2008 Nov; 44(2):288-92. PubMed ID: 18842424
[TBL] [Abstract][Full Text] [Related]
17. Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil.
Dos Santos Nogueira F; Avino VC; Galvis-Ovallos F; Pereira-Chioccola VL; Moreira MAB; Romariz APPL; Molla LM; Menz I
Parasit Vectors; 2019 Feb; 12(1):79. PubMed ID: 30736866
[TBL] [Abstract][Full Text] [Related]
18. Canine leishmaniosis: in vitro efficacy of miltefosine and marbofloxacin alone or in combination with allopurinol against clinical strains of Leishmania infantum.
Farca AM; Miniscalco B; Badino P; Odore R; Monticelli P; Trisciuoglio A; Ferroglio E
Parasitol Res; 2012 Jun; 110(6):2509-13. PubMed ID: 22218923
[TBL] [Abstract][Full Text] [Related]
19. Serial use of pentamidine and miltefosine for treating Leishmania infantum-HIV coinfection.
Faucher JF; Morquin D; Reynes J; Chirouze C; Hoen B; Le Moing V
Parasitol Int; 2016 Oct; 65(5 Pt A):444-6. PubMed ID: 27353022
[TBL] [Abstract][Full Text] [Related]
20. Protective Cellular Immune Response Induction for Cutaneous Leishmaniasis by a New Immunochemotherapy Schedule.
da Silva DAM; Santana FR; Katz S; Garcia DM; Teixeira D; Longo-Maugéri IM; Barbiéri CL
Front Immunol; 2020; 11():345. PubMed ID: 32194563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
